Lactobacillus plantarum Zhang-LL Inhibits Colitis-Related Tumorigenesis by Regulating Arachidonic Acid Metabolism and CD22-Mediated B-Cell Receptor Regulation

• Published in: Nutrients Vol. 15; no. 21; p. 4512
• Main Authors: Zhu, Jingxin, Liu, Wenbo, Bian, Zheng, Ma, Yumeng, Kang, Zixin, Jin, Junhua, Li, Xiangyang, Ge, Shaoyang, Hao, Yanling, Zhang, Hongxing, Xie, Yuanhong
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 25.10.2023
• Subjects: Animals; Apoptosis; Arachidonic Acid - metabolism; Archives & records; Bacteria; Cancer therapies; Carcinogenesis; CD22; Cell Transformation, Neoplastic; Chemotherapy; Clinical trials; Colitis - chemically induced; Colitis - microbiology; Colitis - therapy; Colon; Colorectal cancer; Cytokines; Dextran Sulfate; Disease Models, Animal; Experimental methods; Feces; gut microbiota; Immunotherapy; Inflammatory bowel disease; Lactobacillus plantarum - physiology; Lactobacillus plantarum Zhang-LL; Metabolism; Metabolites; Mice; Microbiota; Microorganisms; Probiotics; Research methodology; RNA, Ribosomal, 16S - genetics; RNA, Ribosomal, 16S - metabolism; Tumor necrosis factor-TNF; Tumors; Viscosity; Beijing China; St Louis Missouri; United States > US; China; colorectal cancer; arachidonic acid metabolism; Lactobacillus plantarum Zhang-LL; CD22; gut microbiota
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15214512

Colorectal cancer (CRC) is a significant health concern and is the third most commonly diagnosed and second deadliest cancer worldwide. CRC has been steadily increasing in developing countries owing to factors such as aging and epidemics. Despite extensive research, the exact pathogenesis of CRC remains unclear, and its causes are complex and variable. Numerous in vitro, animal, and clinical trials have demonstrated the efficacy of probiotics such as in reversing the adverse outcomes of CRC. These findings suggest that probiotics play vital roles in the prevention, adjuvant treatment, and prognosis of CRC. In this study, we constructed a mouse model of CRC using an intraperitoneal injection of azomethane combined with dextran sodium sulfate, while administering 5-fluorouracil as well as high- and low-doses of Zhang-LL live or heat-killed strains. Weight changes and disease activity indices were recorded during feeding, and the number of polyps and colon length were measured after euthanasia. HE staining was used to observe the histopathological changes in the colons of mice, and ELISA was used to detect the expression levels of IL-1β, TNF-α, and IFN-γ in serum. To investigate the specific mechanisms involved in alleviating CRC progression, gut microbial alterations were investigated using 16S rRNA amplicon sequencing and non-targeted metabolomics, and changes in genes related to CRC were assessed using eukaryotic transcriptomics. The results showed that both viable and heat-killed strains of Zhang-LL in high doses significantly inhibited tumorigenesis, colon shortening, adverse inflammatory reactions, intestinal tissue damage, and pro-inflammatory factor expression upregulation. Specifically, in the gut microbiota, the abundance of the dominant flora and was regulated, PGE2 expression was significantly reduced, the arachidonic acid metabolism pathway was inhibited, and CD22-mediated B-cell receptor regulation-related gene expression was upregulated. This study showed that Zhang-LL live or heat-inactivated strains alleviated CRC progression by reducing the abundance of potentially pathogenic bacteria, increasing the abundance of beneficial commensal bacteria, mediating the arachidonic acid metabolism pathway, and improving host immunogenicity.